Lynn Sadowski Mason

Lynn Sadowski Mason is an experienced clinical operations executive with a robust background in the biotechnology and pharmaceutical industries. Currently serving as Vice President of Clinical Operations at Scorpion Therapeutics since April 2024, Lynn has held senior roles at notable companies, including Vice President of Clinical Operations and Data Management at AlloVir, and Executive Vice President of Clinical Operations at Brooklyn ImmunoTherapeutics. With extensive expertise in restructuring clinical operations teams, optimizing vendor management, and delivering significant cost savings, Lynn has demonstrated a strong ability to lead and innovate within clinical settings. Lynn's prior positions at Bristol-Myers Squibb included management of global clinical operations and strategy, emphasizing extensive oversight of clinical trial activities across multiple regions. Lynn holds a Master of Science in Drug and Regulatory Affairs from Massachusetts College of Pharmacy and Health Sciences and a Bachelor’s Degree in Biology/Premed from Indiana University Bloomington.